跳至主要内容
临床试验/NCT03187860
NCT03187860终止不适用

Demonstration of the Diagnostic Character of the Rheology of Mucus

University Hospital, Montpellier1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2019年6月19日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
30
试验地点
1
主要终点
Surface density of active cilia

研究概览

简要总结

This is a prospective study comparing 4 groups: (1) non-smoking controls, (2) smokers without chronic obstructive pulmonary disease (COPD), (3) smokers with COPD, (4) severe asthma.

Bronchial biopsy specimens from each subject will be obtained to produce air-liquid-interface cell cultures. These will then be used to make observations concerning cilia and mucus rheology.

This is a first pilot study. The working hypothesis is that the largest group differences will be found for cilia densities; the latter metric was thus chosen as a primary criterion.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •for non smoking controls:
  • •The subject has given free and informed consent and signed the consent form
  • •The subject is affiliated with or beneficiary of a medical insurance program
  • •The subject has never smoked
  • •No obstructive breathing disorder (forced expiratory volume at one second (FEV1) >70% of predicted value; the ratio of FEV1 to forced vital capacity (FEV1/FVC) is > 0.7)
  • •No known respiratory disease
  • •Inclusion criteria for smokers without COPD:
  • •The subject has given free and informed consent and signed the consent form
  • •The subject is affiliated with or beneficiary of a medical insurance program
  • •Smoker or former smoker (>= 30 pack years)
  • •No obstructive breathing disorder (forced expiratory volume at one second (FEV1) >70% of predicted value; the ratio of FEV1 to forced vital capacity (FEV1/FVC) is > 0.7)
  • •Inclusion criteria for smokers with COPD:
  • •The subject has given free and informed consent and signed the consent form
  • •The subject is affiliated with or beneficiary of a medical insurance program
  • •Smoker or former smoker (>= 30 pack years)
  • •Subject presenting with COPD: FEV1/FVC < 0.7 (based on spirometry values in the medical file and performed in the 3 months prior to inclusion)
  • •The subject requires bronchial fibroscopy (decision made by pneumologist)
  • •COPD of grade "2" or "3" according to GOLD criteria (Global Initiative for Chronic Obstructive Lung Disease)
  • •Inclusion criteria for subjects with severe asthma:
  • •The subject has given free and informed consent and signed the consent form
  • •The subject is affiliated with or beneficiary of a medical insurance program
  • •Non-smoker or former smoker (<10 pack years)
  • •Subject presenting with severe asthma: FEV1/FVC >= 0.7 and FEV1 < 80%
  • •The subjects requires bronchial fibroscopy (decision made by pneumologist)

排除标准

  • •The subject has an extensive neoplastic disease
  • •The subject has another active lung disease (tuberculosis, pulmonary interstitium disease, active or recent pulmonary infection)
  • •The subject has had a recent psychiatric disorder (within one year prior to inclusion and documented by a specialist consultation)
  • •Emergency situations (object extractions...)
  • •Subject consuming illicit drugs or alcohol
  • •The subject is in an exclusion period determined by a previous study
  • •The subject is under judicial protection, or is an adult under any kind of guardianship
  • •It is impossible to correctly inform the patient
  • •The subject cannot fluently read French

研究组 & 干预措施

Non-smoking controls

Experimental

Subjects in this group have never smoked and have no known lung disorders.

Intervention: Bronchial Biopsy + ALI culture (Air Liquid Interface)

干预措施: Bronchial Biopsy (Procedure)

Non-smoking controls

Experimental

Subjects in this group have never smoked and have no known lung disorders.

Intervention: Bronchial Biopsy + ALI culture (Air Liquid Interface)

干预措施: ALI culture (Other)

Smokers without COPD

Experimental

Subjects in this group are smokers or former smokers who do not have signs of obstructive disease (no chronic obstructive pulmonary disease (COPD))

Intervention: Bronchial Biopsy + ALI culture

干预措施: Bronchial Biopsy (Procedure)

Smokers without COPD

Experimental

Subjects in this group are smokers or former smokers who do not have signs of obstructive disease (no chronic obstructive pulmonary disease (COPD))

Intervention: Bronchial Biopsy + ALI culture

干预措施: ALI culture (Other)

Smokers with COPD

Experimental

Subjects in this group are smokers or former smokers who have COPD

Intervention: Bronchial Biopsy + ALI culture

干预措施: Bronchial Biopsy (Procedure)

Smokers with COPD

Experimental

Subjects in this group are smokers or former smokers who have COPD

Intervention: Bronchial Biopsy + ALI culture

干预措施: ALI culture (Other)

Severe asthma

Experimental

Subjects in this group are non-smokers or former (light) smokers who have severe asthma.

Intervention: Bronchial Biopsy + ALI culture

干预措施: Bronchial Biopsy (Procedure)

Severe asthma

Experimental

Subjects in this group are non-smokers or former (light) smokers who have severe asthma.

Intervention: Bronchial Biopsy + ALI culture

干预措施: ALI culture (Other)

结局指标

主要结局

Surface density of active cilia

时间窗: Day 0 + approximately 2 months of cell culture time

Surface density of active cilia

次要结局

  • Mucus viscosity(Day 0 + approximately 2 months of cell culture time)
  • Cilia beat orientation(Day 0 + approximately 2 months of cell culture time)
  • Cilia beating frequency(Day 0 + approximately 2 months of cell culture time)
  • Mucus elasticity(Day 0 + approximately 2 months of cell culture time)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验